WÄSSRIGE FORMULIERUNG MIT 5-AMINOLEVULINSÄURE ODER DERGLEICHEN

European patent · EP3508200 · In force

Register entry

Publication number
EP3508200
Application number
EP17846245
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 23, 2017
Published
Jul 10, 2019
Granted
Apr 10, 2024
Protection ends at the latest
Aug 22, 2037
Next annual fee due
Aug 31, 2026
IPC classes
A61K 31/197 (2006.01)
A61K 31/22 (2006.01)
A61K 31/221 (2006.01)
A61K 31/222 (2006.01)
A61K 31/295 (2006.01)
A61K 9/06 (2006.01)
A61K 9/08 (2006.01)
A61K 47/02 (2006.01)
A61K 47/12 (2006.01)
Priority
JP 2016171753 02.09.2016
PCT application
PCT/JP2017/030107 23.08.2017
PCT publication
WO2018/043240 08.03.2018
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  2. Feb 19, 2025

    Change

    Published in Swissreg on 19.02.2025

  3. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  4. Apr 19, 2024

    Agent entered

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 19.04.2024

  5. Apr 10, 2024

    Granted

    Published in Swissreg on 10.04.2024

Parties

Holder

SBI Pharmaceuticals Co., Ltd.

6-1, Roppongi 1-chome Minato-ku, Tokyo 106-6020, JP

Agent

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventor

MORISHITA, Mika

Kobe-shi Hyogo 650-0047, JP

ISHIZUKA, Masahiro

Tokyo 106-6020, JP

OTA, Urara

Kobe-shi Hyogo 650-0047, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.